Trials / Completed
CompletedNCT01402570
Glutathione and Health With Post-Polio Syndrome
Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 50 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In this study, people who have symptoms of post polio will take oral glutathione supplements for three months. Their levels of fatigue, physical activity and sleep efficiency will be assessed.
Detailed description
Subjects will take a glutathione supplement by mouth for three months after an initial medical visit, blood draw and physical exam. There are four timepoints during the three months when subjects will fill out surveys and record food intake and sleep times in diaries for seven days. They will also wear a small device for seven days, a Sensewear monitor that records physical activity, body temperature and other measures. After the fourth timepoint they will return to the medical center for another physical exam and blood draw. Physicians trained in physical medicine and rehabilitation will be monitoring the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glutathione | glutathione is a dietary supplement and an antioxidant. Subjects will take 1000 mg per day for three month. Each capsule contains 500 mg glutathione. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2013-04-01
- Completion
- 2013-07-01
- First posted
- 2011-07-26
- Last updated
- 2017-02-17
- Results posted
- 2017-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01402570. Inclusion in this directory is not an endorsement.